In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.  Related Content:  Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease Donanemab in Early Symptomatic Alzheimer Disease 

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease

Author interviews that explore the latest clinical reviews.

Medicine

Science & Medicine

Science

Health & Fitness

Interview with Wanda K. Nicholson, MD, MPH, MBA, USPSTF Chair and coauthor of Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.  Related Content:  Collaborative Modeling to Compare Different Breast Cancer Screening Strategies Screening for Breast Cancer Screening for Breast Cancer Screening for Breast Cancer Toward More Equitable Breast Cancer Outcomes 

USPSTF Recommendation: Screening for Breast Cancer

Interstitial lung disease (ILD), characterized by inflammation and fibrosis of the lungs, is associated with progressive dyspnea and results in approximately 25 000 to 30 000 deaths in the US each year. Toby M. Maher, MD, MSc, PhD, of Keck Medicine of USC, discusses the diagnosis and management of ILD with JAMA Deputy Editor Mary McGrae McDermott, MD.  Related Content:  Interstitial Lung Disease 

Diagnosis and Treatment of Interstitial Lung Disease

Dislocated hips in newborns can lead to complex surgery, interruption to family life, and premature osteoarthritis. Daniel Perry, MBChb(Hons), PhD, of Alder Hey Children's Hospital, University of Liverpool, discusses the clinical diagnosis of dislocated hips in newborns with JAMA Associate Editor David Simel, MD, MHS.  Related Content:  Does This Infant Have a Dislocated Hip? 

Clinical Diagnosis of Dislocated Hips in Newborns

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD.  Related Content:  Systemic Lupus Erythematosus 

Diagnosis and Treatment of Systemic Lupus Erythematosus

Falls are common in adults older than 65 years and can cause substantial morbidity and mortality. JAMA Associate Editor David Simel, MD, MHS, discusses risk assessment and prevention of falls in older adults with Karin E. Ouchida, MD, of Weill-Cornell Medical University, and author Cathleen Colon-Emeric, MD, of Duke University.  Related Content:  Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults Falls Prevention for Older Adults 

Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease

Download our free app to listen on your phone